EUVIMEDEUVIMED entdecken
Crossref

Engineered Bacteria Manipulate Cysteine Metabolism to Boost Ferroptosis‐Based Pancreatic Ductal Adenocarcinoma Therapy

Chaoqiang Qiao, Lexuan Wang, Chuting Huang, Qian Jia, Weier Bao, Peilin Guo, Dengxu Tan, Zhuang Chen, Changhong Shi, Zhiping Rao, Ruili Zhang, Wei Wei iD und 1 weitere

Advanced Materials · 2025-02 · 37 (6)

DOI: 10.1002/adma.202412982 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Materials, online erschienen am 18.12.2024. Verfasst von Chaoqiang Qiao und 12 weiteren Autor:innen. Beteiligte Einrichtung: Engineering Research Center of Molecular & Neuroimaging, Ministry of Education, School of Life Science and Technology, Xidian University, Xi'an, 7101…. Hauptthemen laut MEDLINE: Cysteine, Ferroptosis, Carcinoma, Pancreatic Ductal, Pancreatic Neoplasms. Die Arbeit wurde bisher 40-mal zitiert (Crossref) und nennt 45 Literaturangaben. Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China, China Postdoctoral Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cysteine metabolism is a key determinant of the defense against ferroptosis in pancreatic ductal adenocarcinoma (PDAC). Blocking cysteine metabolism may trigger potent ferroptosis in PDAC cells by generating lipid peroxides during tumor metabolic processes. However, current methods to limit cysteine availability fall short, failing to efficiently block cysteine metabolism due to inadequate tumor targeting and compensatory cysteine sources. Inspired by sulfur‐metabolizing bacteria, synthetic biology to develop an engineered bacterium capable of directly depleting cysteine to block its metabolism is used. Acting as a living drug, these engineered bacteria colonize the tumor and continuously produce engineered cyst(e)inase enzyme (CGL) under the stimulation of tumor hypoxia. The CGL exhausts the substrate cysteine, completely impeding cysteine metabolism. This process dismantles the ferroptosis defense system in PDAC cells, triggers potent ferroptosis, and achieves efficient treatment. The results demonstrate that engineered bacteria designed for cysteine metabolism modulation possess unparalleled advantages in efficacy, persistence, and precision in blocking cysteine metabolism, making them highly suitable for effective ferroptosis treatment of PDAC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CysteineFerroptosisCarcinoma, Pancreatic DuctalPancreatic NeoplasmsHumansCell Line, TumorAnimalsMice

Stichwörter der Autor:innen

cysteine metabolismengineered bacteriaferroptosis treatment

Substanzen

Cysteine

Autor:innen und Institutionen

  • Engineering Research Center of Molecular & Neuroimaging, Ministry of Education, School of Life Science and Technology, Xidian University, Xi'an, 710126, P. R. China.
  • Guangzhou Institute of Technology, Xidian University, Guangzhou, 510555, P. R. China.
  • State Key Laboratory of Biochemical Engineering, Institute of Process Engineering, Chinese Academy of Sciences, Beijing, 100190, P. R. China.
  • Key Laboratory of Biopharmaceutical Preparation and Delivery, Chinese Academy of Sciences, Beijing, 100190, P. R. China.
  • Laboratory Animal Center, Air Force Medical University, Xi'an, 710032, P. R. China.
  • School of Chemical Engineering, University of Chinese Academy of Sciences, Beijing, 100049, P. R. China.

ORCID-Profile: Wei Wei, Zhongliang Wang

Förderung

  • National Key Research and Development Program of China
  • National Natural Science Foundation of China
  • China Postdoctoral Science Foundation
  • Innovation Capability Support Program of Shaanxi
  • Shaanxi Fundamental Science Research Project for Chemistry and Biology
  • Key Research and Development Program of Shaanxi
  • Postdoctoral Research Project of Shaanxi Province
  • Fundamental Research Funds for the Central Universities

Zitieren

APA

Qiao, C., Wang, L., Huang, C., Jia, Q., Bao, W., Guo, P., Tan, D., Chen, Z., Shi, C., Rao, Z., Zhang, R., Wei, W., & Wang, Z. (2025). Engineered Bacteria Manipulate Cysteine Metabolism to Boost Ferroptosis‐Based Pancreatic Ductal Adenocarcinoma Therapy. Advanced Materials, 37(6). https://doi.org/10.1002/adma.202412982

Vancouver

Qiao C, Wang L, Huang C, Jia Q, Bao W, Guo P, et al. Engineered Bacteria Manipulate Cysteine Metabolism to Boost Ferroptosis‐Based Pancreatic Ductal Adenocarcinoma Therapy. Advanced Materials. 2025;37(6). doi:10.1002/adma.202412982

BibTeX
@article{Qiao2025,
  author = {Qiao, Chaoqiang and Wang, Lexuan and Huang, Chuting and Jia, Qian and Bao, Weier and Guo, Peilin and Tan, Dengxu and Chen, Zhuang and Shi, Changhong and Rao, Zhiping and Zhang, Ruili and Wei, Wei and Wang, Zhongliang},
  title = {Engineered Bacteria Manipulate Cysteine Metabolism to Boost Ferroptosis‐Based Pancreatic Ductal Adenocarcinoma Therapy},
  journal = {Advanced Materials},
  year = {2025},
  volume = {37},
  number = {6},
  doi = {10.1002/adma.202412982}
}
Kostenlos starten →